An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...

A 15-year-old Simsboro teen is making history as the first person in Louisiana and the fourth in the world to receive a ...

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an ...

“What we’re trying to do is recreate how the pancreas normally should work,” Odom said. “So we’re using insulin as a hormone, ...

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...

At the American Diabetes Association annual meeting, findings from the SURPASS-EARLY trial added to growing evidence that ...

In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal symptoms than those taking a placebo. Reading time 3 minutes A little ...

Add Yahoo as a preferred source to see more of our stories on Google. It's a development millions of people living with Type 1 diabetes never thought would happen. A new study is showing promising a ...

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.

Experts hail ‘new age of diabetes treatment’ as drug approved on NHS - Teplizumab is approved for children aged eight and over ...